Loss of the perforin cytotoxic pathway predisposes mice to experimental cytomegalovirus retinitis

Journal of Virology

Volumn 77, Issue 6, 2003, Pages 3402-3408

  Dix, Richard D ^a   Podack, Eckhard R ^b   Cousins, Scott W ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; MESSENGER RNA; PERFORIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETINA DEGENERATION; RETINITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD95; CYTOMEGALOVIRUS RETINITIS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; EYE; EYE INFECTIONS, VIRAL; FAS LIGAND PROTEIN; HERPESVIRIDAE INFECTIONS; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; MUROMEGALOVIRUS; PORE FORMING CYTOTOXIC PROTEINS; RETINA;

EID: 0037333391     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.6.3402-3408.2003     Document Type: Article

References (51)

1. Atherton, S. S., C. K. Newell, M. Y. Kanter, and S. W. Cousins. 1991. Retinitis in euthymic mice following inoculation of murine cytomegalovirus (MCMV) via the supraciliary route. Curr. Eye Res. 10:667-677.
2. Atherton, S. S., C. K. Newell, M. Y. Kanter, and S. W. Cousins. 1992. T cell depletion increases susceptibility to murine cytomegalovirus retinitis. Investig. Ophthalmol. Vis. Sci. 33:3353-3360.
3. Bigger, J. E., C. A. Thomas III, and S. S. Atherton. 1998. NK cell modulation of murine cytomegalovirus retinitis. J. Immunol. 160:5826-5831.
4. Britt, W. J., and C. A. Alford. 1996. Cytomegalovirus, p. 2493-2523. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
5. Celi, F. S., M. E. Zenilman, and A. R. Shuldiner. 1993. A rapid and versatile method to synthesize internal standards for competitive PCR. Nucleic Acids Res. 21:1047-1056.
6. Chang, H. Y., H. Nishotoh, X. Yang, H. Ichijo, and D. Baltimore. 1998. Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 281:1860-1863.
7. Chang-Fang, J., and M. Marina. 1994. Rapid construction of deleted DNA fragments for use as internal standards in competitive PCR. PCR Methods Appl. 3:252-255.
8. Cunningham, E. T., and T. P. Margolis. 1998. Ocular manifestations of HIV infection. N. Engl. J. Med. 339:236-244.
9. Dix, R. D. 1998. Systemic murine cytomegalovirus infection of mice with retrovirus-induced immunodeficiency results in ocular infection but not retinitis. Ophthalm. Res. 30:295-301.
10. Dix, R. D., C. C. Cray, and S. W. Cousins. 1994. Mice immunosuppressed by murine retrovirus infection (MAIDS) are susceptible to cytomegalovirus retinitis. Curr. Eye Res. 13:587-595.
11. Dix, R. D., C. Cray, and S. W. Cousins. 1997. Antibody alone does not prevent experimental cytomegalovirus retinitis in mice with retrovirus-induced immunodeficiency (MAIDS). Ophthalm. Res. 29:381-392.
12. Dix, R. D., M. Giedlin, and S. W. Cousins. 1997. Systemic cytokine immunotherapy for experimental cytomegalovirus retinitis in mice with retrovirus-induced immunodeficiency. Investig. Ophthalmol. Vis. Sci. 38:1411-1417.
13. Duan, Y., Z. Yi, and S. S. Atherton. 1994. Dissemination and replication of murine cytomegalovirus after supraciliary invoulation in immunosuppressed mice. Investig. Ophthalmol. Vis. Sci. 35:1124-1131.
14. Ferguson, T. A., and T. S. Griffith. 1997. A vision of cell death: insights into immune privilege. Immunol. Rev. 156:167-184.
15. Gao, E.-R., X.-H. Yu, P.-C. Lin, H. Zhang, and H. J. Kaplan. 1995. Intraocular viral replication after systemic murine cytomegalovirus infection requires immunosuppression. Investig. Ophthalmol. Vis. Sci. 36:2322-2327.
16. Goldstein, P. 1995. Fas-based T cell-mediated cytotoxicity. Curr. Top, Microbiol. Immunol. 198:25-37.
17. Griffin, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189-1192.
18. Hartley, J. W., T. N. Fredrickson, R. A. Yetter, M. Makino, and H. C. Morse III. 1989, Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J. Virol. 63:1223-1231.
19. Ho, M. 1994. Advances in understanding cytomegalovirus infection after transplantation. Transplant. Proc. 26:7-11.
20. Holland, G. N., A. Tufail, and M. C. Jordan. 1996. Cytomegalovirus disease, p. 1088-1130. In J. S. Pepose, G. N. Holland, and K. R. Wilhelmus (ed.), Ocular infections and immunity. C.V. Mosby Co., Inc., St. Louis, Mo.
21. Inoue, Y., P. Minasi, and J. O. Oh. 1993. The role of natural killer cells in murine cytomegalovirus eye infections. Investig. Ophthalmol. Vis. Sci. 34: 3353-3360.
22. Jabs, D. A., and J. G. Bartlett. 1997. AIDS and ophthalmology: a period of transition. Am. J. Ophthalmol. 124:227-233.
23. Jenne, D. E., and J. Tschopp. 1988. Granyzmes, a family of serine proteases released from granules of cytolytic T-lymphocytes upon T-cell receptor stimulation. Immunol. Rev. 103:53-71.
24. Jolicoeur, P. 1991. Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study AIDS pathogenesis. FASEB J. 5:2398-2405.
25. Ju, S.-T., D. J. Panka, H. Cui, R. Ettinger, J. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature (London) 373:444-448.
26. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zindernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:313-337.
27. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraitere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528-530.
28. Kaplan, H. J., M. A. Leibole, T. Tezel, and T. A. Ferguson. 1999. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina. Nat. Med. 5:292-297.
29. Kercher, L., and B. M. Mitchell. 2000. Immune transfer protects severely immunosuppressed mice from murine cytomegalovirus retinitis and reduces the viral load in ocular tissue. J. Infect. Dis. 182:652-661.
30. Kupperman, B. D., J. G. Petty, D. D. Richman, W. C. Mathews, S. C. Fullerton, L. S. Rickman, and W. R. Freeman. 1993. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am. J. Ophthalmol. 115:575-582.
31. Li, B., C. Hartono, R. Ding, V. K. Sharma, R. Ramaswamy, B. Quin, D. Serur, J. Mouradian, J. E. Schwartz, and M. Suthanthiran. 2001. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N. Engl. J. Med. 344:947-954.
32. Lowder, C. Y., C. P. Butler, E. M. Dodds, M. Secic, and C. Recillas-Gispert. 1995. CD8+ T lymphocytes and cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Am. J Ophthalmol. 120:283-290.
33. Lowin, B., F. Beermann, A. Schmidt, and J. Tschopp. 1994. A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 91:11571-11575.
34. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650-652.
35. Lowin, B., M. C. Peitsch, and J. Tschopp. 1995. Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr. Top. Microbiol. Immunol. 198:1-24.
36. Mogil, R. J., L. Fadvanyi, R. Gonzalez-Quintial, R. Miller, G. Mills, A. N. Theofilopoulos, and D. R. Green. 1995. Fas (CD95) participates in peripheral T cell depletion and associated apoptosis in vivo. Int. Immunol. 7:1451-1458.
37. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Schaffidi, J. D. Bretz, M. Zhang, R. Gentz, M. Mann, P. H. Krammes, M. E. Peter, and V. M. Dixit. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signaling complex. Cell 85:817-827.
38. Nagata, S., and P. Goldstein. 1995. The Fas death factor. Science 267:1449-1461.
39. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16:39-43.
40. Palella, F. J., Jr., K. M. Delaney, A. C. Moorman, J. O. Loveless, J. Fuhrer, G. A. Satten, D. J. Aschman, S. D. Holmberg, and the HIV Outpatient Study Investigators. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338: 853-860.
41. Peacock, C. D., S. D. Olver, and P. Price. 1997. Effect of a retroviral immunodeficiency syndrome on murine cytomegalovirus-induced hepatitis. Am. J. Pathol. 150:1089-1100.
42. Podack, E. R. 1995. Perforin, killer cells and gene transfer immunotherapy for cancer. Curr. Top. Microbiol. Immunol. 198:121-130.
43. Rook, A. H., H. Masur, H. C. Lane, W. Frederick, T. Kasahara, A. M. Macher, J. Y. Djeu, J. F. Manischewitz, L. Jackson, A. S. Fauci, and G. V. Quinnan, Jr. 1983. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes of patients with the acquired immune deficiency syndrome. J. Clin. Investig. 72:398-403.
44. Russell, J. H., and T. J. Ley. 2002. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20:323-370.
45. Schacker, T., and L. Corey. 1997. Herpesvirus infections in human immunodeficiency virus-infected persons, p. 267-280. In V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (ed.), AIDS: biology, diagnosis, treatment, and prevention, 4th ed. Lippincott-Raven Publishers, Philadelphia, Pa.
46. Shanley, J. D., L. Biczak, and S. J. Forman. 1993. Acute murine cytomegalovirus infection induces lethal hepatitis. J. Infect. Dis. 167:264-269.
47. Smith, K. A. 1988. Interleukin-2: inception, impact, and implications. Science 240:1169-1176.
48. Smyth, M. J., and J. A. Trapani. 1998. The relative role of lymphocyte granule exocytosis versus death receptor-mediated cytotoxicity in viral pathophysiology. J. Virol. 72:1-9.
49. Streilein, J. W. 1999. Regional immunity and ocular immune privilege, p. 11-38. In J. W. Streilein (ed.), Immune response and the eye, vol. 73. Karger, Basel, Switzerland.
50. Stuart, P. M., T. S. Griffith, N. Usui, J. Pepose, X. Yu, and T. A. Ferguson. 1997. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J. Clin. Investig. 99:396-402.
51. Walsh, C. M., M. Matloubian, C.-C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, M. T. F. Huang, J. D.-E. Young, R. Ahmed, and W. R. Clark. 1994. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. USA 91:10854-10858.